Liu L, Deng Y, Li L, Yang X, et al. Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysis. PLoS One 2024;19:e0310696.
PMID: 39536001